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CASE STUDY
A rare case of intramedullary 
‘whorling-sclerosing’ variant meningioma
Ghazala Perven1, Pouya Entezami2 and Daniel Gaudin2*
Abstract 
A 52-year-old man with a seven-year history of progressive weakness, gait problems, and pain in his extremities pre-
sented with subacute worsening of his symptoms. Examination revealed weakness in all four extremities, increased 
tone, hyperreflexia, and sensory deficits. MRI of the cervical spine showed an area of signal abnormality and abnormal 
enhancement within the cervical cord at the C5–C6 level. The patient initially underwent biopsy followed a few days 
later by a debulking surgery. Postoperatively, the patient showed improvement in strength as well as ambulation. 
Intraoperatively, the lesion was confirmed to be intramedullary without any dural attachments. Histopathological 
examination revealed an extensively hyalinized tumor with sparse collections of cells that were immunopositive for 
both cytokeratin and GFAP, and immunonegative for EMA and progesterone receptor. This is an unusual pattern of 
expression, with cytokeratin immunopositivity suggesting a meningioma and GFAP immunopositivity suggesting a 
glioma. Considering the combination of extensive hyalinization with cytokeratin positivity the tumor was thought 
to be most consistent with a hyalinized meningioma with GFAP positivity. GFAP-positive meningiomas are rare, and 
these include the recently described ‘whorling-sclerosing’ variant. Only three cases of this tumor have been previ-
ously reported, all of which were intracranial. This is the first reported case of an intramedullary whorling-sclerosing 
meningioma.
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Background
Meningiomas are generally benign tumors originating 
from non-neuroepithelial progenitor cells, known as 
arachnoid cap cells. The WHO classification identifies 
fifteen distinct histological variants (Kleihues et al. 2002) 
but other variants exist as well. Intraspinal meningiomas 
are relatively frequent primary tumors of the spinal cord. 
Approximately 25% of all primary spinal cord tumors are 
meningiomas (Chamberlain and Tredway 2011).
Meningiomas found within the spinal canal most com-
monly affect the thoracic region (80%), though cervical 
(15%) and lumbosacral (5%) tumors are also observed 
(Van Goethem et al. 2004). These tumors are most com-
monly intradural and extramedullary, though there 
are a few reports in the literature of intramedullary 
meningiomas.
We present a 52-year-old man with a whorling-scle-
rosing variant meningioma of the spine. Only three 
cases with this histological pattern have previously been 
reported, and all of these were intracranial (Pope et  al. 
2003; Haberler et al. 2002). We present the first reported 
spinal tumor with this histological presentation.
Case report
A 52-year-old man with a seven-year history of progres-
sive weakness, gait problems, and pain in his extremities 
presented with subacute worsening of his symptoms. 
Initially, he was hesitant about undergoing surgery and 
was managed conservatively, but his weakness contin-
ued to progress and he had become wheelchair-bound. 
Examination revealed weakness in all four extremities, 
increased tone, hyperreflexia, and sensory deficits. Bowel 
and bladder functions were spared. The patient received 
corticosteroids that helped alleviate some of his symp-
toms but, due to the progressive course, the patient con-
sented for surgery.
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MRI of the cervical spine showed an area of signal 
abnormality as well as abnormal enhancement within the 
cervical cord at the C5–C6 level. The lesion was hypoin-
tense on T1 (Figure 1) and hyperintense on T2 sequence 
(Figure  2) extending one vertebral level up and one 
vertebral level down. The cord was noted to be expanded 
at the level of the lesion.
The patient underwent a biopsy, via C4–C5 laminec-
tomy and C6 hemilaminectomy. Midline dissection of 
the cord at C5 revealed a tan-grey tumor, which was 
Figure 1 Sagittal T1 MRI (a) of the cervical spinal cord shows an area of mixed signal intensity as well as slight expansion at C4–C5 and C5–C6. 
Post-contrast images (b) show an area of enhancement within the cord at the level of C4–C5.
Figure 2 Sagittal T2 MRI (a) and sagittal STIR (b) of the cervical spinal cord shows heterogeneous signal intensity with surrounding edema at C4–
C5.
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biopsied. One week postoperatively patient underwent 
debulking surgery under ultrasound guidance and a 
tumor with dimensions of 1.1 cm × 4 mm × 4 mm was 
removed using microsurgical technique (Figure 3).
Postoperatively, the patient showed improvement in 
strength as well as ambulation. By 6 months he was able 
to ambulate using a walker for short distances. He also 
reported significant improvement in pain and paresthesias 
in his arms and legs, though he continued to have residual 
neurological deficits, including a right hand contracture.
Histopathological examination revealed an extensively 
hyalinized tumor with sparse collections of cells. The 
collagenous nature of the hyalinized material was con-
firmed with a trichrome stain (Figure  4a). The benign 
nature of the tumor was suggested by the bland nature of Figure 3 Intraoperative appearance of the tumor after myelotomy.
Figure 4 Histological appearance with a trichrome stain; b immunopositive for cytokeratin; c immunopositive for GFAP.
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the cellular component and was confirmed with a KI-67 
immunoreaction, which showed almost no proliferating 
cells. A PAS stain showed no eosinophilic granular bod-
ies. The cells were immunopositive for both cytokeratin 
(Figure 4b) and GFAP (Figure 4c), and immunonegative 
for epithelial membrane antigen (EMA) and progester-
one receptor.
Discussion
We present the first reported case of an intraspinal, 
GFAP-positive meningioma. Our case is similar to two 
cases described by Haberler et  al. (2002) and one case 
described by Pope et  al. (2003) in both histological and 
immunological findings. These authors suggested that 
this particular histological pattern be named the ‘whor-
ling-sclerosing’ variant of meningioma. There are a num-
ber of examples of GFAP-positive meningioma reported 
in literature but these all are intracranial and extra-axial 
(Table 1).
Glial fibrillary acidic protein (GFAP) is specific for neu-
roglial filaments and has been used as a reliable marker 
for normal, reactive, and neoplastic astrocytes. It is a 
structural protein which is the predominant component 
of glial intermediate filaments. Therefore, a tissue immu-
nopositive for GFAP is assumed to be of glial origin. 
More recently GFAP immunopositivity has been recog-
nized in other types of neoplastic and normal tissues as 
well, including epiglottic cartilage, renal carcinoma meta-
static to brain, malignant pleomorphic adenoma of the 
salivary glands, and papillary meningioma (Budka 1986).
Our case also represents a rare example of cervical 
intramedullary meningioma. Completely intramedul-
lary meningiomas in the spinal cord are rare, with only 
six reported cases in the literature (Table  2). Five of 
these tumors were located in the cervical area with one 
extending up to the cervicomedullary junction. This is 
in contrast to extramedullary meningiomas, which are 
preferentially located in thoracic segments of the cord. 
The histopathological appearance of the six reported 
intramedullary meningiomas was variable, with two 
being clear cell meningiomas (Park et al. 2006; Jallo et al. 
2001), one a transitional meningioma (Moriuchi et  al. 
1996), one an atypical grade II meningioma (Sahni et al. 
2008), one a fibroblastic meningioma (Salvati et al. 2007), 
Table 1 GFAP-positive meningiomas; review of cases in the literature
GFAP glial fibrillary acidic protein, NSE neuron specific enolase, EMA epithelial membrane antigen, SYN synaptophysin, NFP neurofilament protein, CHROM A 
chromogranin A, FN fibronectin, CEA carciniembryonic antigen, MU 128-UC smooth muscle actin.
References Age/gender Location Histological diagnosis Immunohistochemistry
Positive Negative
Budka (1986) 48 years/F Extra-axial left parietal Papillary meningioma GFAP, vimentin,  
cytokeratin
Wanschitz et al. 
(1995)
24 years/F Suprasellar Chordoid or papillary 
meningioma
GFAP, NSE, S100, vimentin, 
cytokeratin, and EMA
SYN, NFP, CHROM A, CEA, 
FN, desmin, MU 128-UC
Su et al. (1997) 63 years/M Extra-axial in the right 




EMA, vimentin, GFAP S 100 protein
Haberler et al. (2002) 48 years/F Bifronto-basal invading 








Haberler et al. (2002) 77 years/M Dural based right occipital Whorling-sclerosing vari-
ant of meningioma








EMA, vimentin, GFAP Cytokeratin, CEA
Table 2 Intramedullary spinal cord meningiomas; review of cases in literature
References Age/gender Location Histology
Moriuchi et al. (1996) 54 years/F C2–C4 Transitional meningioma
Park et al. (2006) 65 years/F T9–T10 Clear cell meningioma
Sahni et al. (2008) 42 years/M C3–T2 Atypical meningioma (WHO grade 2)
Salvati et al. (1992) 67 years/F C2–C4 Fibroblastic meningioma
Salehpour et al. (2008) 21 years/M Cervicomedullary junction–C2 Syncytial type meningioma
Jallo et al. (2001) 22 months/F C3–C5 Clear cell meningioma
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and one a syncytial-type meningioma (Salehpour et  al. 
1992). This is the first reported case of an intramedullary 
spinal cord whorling-sclerosing meningioma.
Conclusion
Our report confirms previous reports that spinal menin-
giomas can be intramedullary and that GFAP positivity is 
not specific for glial tumors. Fortunately, management is 
unchanged for these variants and surgical resection car-
ries a good prognosis. Nevertheless, the ‘whorling-scle-
rosing’ variant of meningioma is a rare type of neoplasm 
with a specific histopathological and immunological pro-
file that should be recognized.
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